Reversal of a Defunctioning Ileostomy 3 Weeks After the Index Operation, RCT
NCT ID: NCT05192018
Last Updated: 2022-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-12-25
2023-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Closure of Protective Ileostomy in Rectal Cancer Patients
NCT02997267
Fortune of Temporary Ileostomies in Patients After Rectal Cancer Surgery
NCT02532478
Early Versus Late Closure of Preventive Ileostomy
NCT03796702
Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer
NCT02665026
Defunctioning Cannula Ileostomy After Lower Anterior Resection of Rectal Cancer
NCT01980238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exclusion criteria
* When performed to cover unsatisfactory anastomosis
* Positive air-leak test
* Those experienced postoperative complications
* Those with preoperative (1st operation) albumin below 3.5gm/dL.
* Immunocompromised patients e.g on steroids or have uncontrolled DM.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
This group will have their ileostomy reversed after 3 weeks from the index operation. All procedures were performed by the same senior surgeons. The duration of the operation was noted and the ease of reversal of stoma and closure of abdominal wall were assessed on ascale of 0-10 (0 = difficult, 10 = easy) by the operating surgeons.
Early reversal of a defunctiong ileostomy
Early reversal of a defunctiong ileostomy after 3 weeks of its creation
Group B
This group will be discharged home after the primary colorectal surgery with a defunctioning ileostomy and brought back after an interval of 3 months ,or after completion of their adjuvant therapy, for reversal. All procedures were performed by the same senior surgeons. The duration of the operation was noted and the ease of reversal of stoma and closure of abdominal wall were assessed on ascale of 0-10 (0 = difficult, 10 = easy) by the operating surgeons.
Early reversal of a defunctiong ileostomy
Early reversal of a defunctiong ileostomy after 3 weeks of its creation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early reversal of a defunctiong ileostomy
Early reversal of a defunctiong ileostomy after 3 weeks of its creation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Positive air-leak test
* Those experienced postoperative complications
* Those with preoperative (1st operation) albumin below 3.5gm/dL.
* Immunocompromised patients e.g on steroids or have uncontrolled DM.
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed M Mahmoud, Professor
Role: STUDY_DIRECTOR
National Cancer Institute, Cairo University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Debakey3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.